Advertisement
Canada markets open in 8 hours 33 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7325
    +0.0001 (+0.02%)
     
  • CRUDE OIL

    83.84
    +0.27 (+0.32%)
     
  • Bitcoin CAD

    87,679.98
    -135.98 (-0.15%)
     
  • CMC Crypto 200

    1,387.67
    +5.10 (+0.37%)
     
  • GOLD FUTURES

    2,347.80
    +5.30 (+0.23%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,772.00
    +204.50 (+1.16%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    38,018.67
    +390.19 (+1.04%)
     
  • CAD/EUR

    0.6828
    +0.0007 (+0.10%)
     

Are Investors Undervaluing Quanex Building Products Corporation (NYSE:NX) By 27%?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Quanex Building Products Corporation (NYSE:NX) as an investment opportunity by taking the foreast future cash flows of the company and discounting them back to today's value. This is done using the Discounted Cash Flow (DCF) model. Don't get put off by the jargon, the math behind it is actually quite straightforward.

Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

ADVERTISEMENT

View our latest analysis for Quanex Building Products

Crunching the numbers

We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

Generally we assume that a dollar today is more valuable than a dollar in the future, so we discount the value of these future cash flows to their estimated value in today's dollars:

10-year free cash flow (FCF) estimate

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Levered FCF ($, Millions)

$53.36

$61.22

$63.95

$66.47

$68.85

$71.14

$73.38

$75.59

$77.81

$80.05

Growth Rate Estimate Source

Analyst x2

Analyst x2

Est @ 4.46%

Est @ 3.94%

Est @ 3.58%

Est @ 3.32%

Est @ 3.15%

Est @ 3.02%

Est @ 2.93%

Est @ 2.87%

Present Value ($, Millions) Discounted @ 10.51%

$48.29

$50.12

$47.38

$44.56

$41.76

$39.05

$36.44

$33.97

$31.64

$29.45

Present Value of 10-year Cash Flow (PVCF)= $402.67m

"Est" = FCF growth rate estimated by Simply Wall St

After calculating the present value of future cash flows in the intial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 10-year government bond rate of 2.7%. We discount the terminal cash flows to today's value at a cost of equity of 10.5%.

Terminal Value (TV) = FCF2029 × (1 + g) ÷ (r – g) = US$80m × (1 + 2.7%) ÷ (10.5% – 2.7%) = US$1.1b

Present Value of Terminal Value (PVTV) = TV / (1 + r)10 = $US$1.1b ÷ ( 1 + 10.5%)10 = $388.72m

The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is $791.39m. In the final step we divide the equity value by the number of shares outstanding. This results in an intrinsic value estimate of $24.09. Relative to the current share price of $17.54, the company appears a touch undervalued at a 27% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.

NYSE:NX Intrinsic value, June 24th 2019
NYSE:NX Intrinsic value, June 24th 2019

Important assumptions

Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Quanex Building Products as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 10.5%, which is based on a levered beta of 1.306. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Whilst important, DCF calculation shouldn’t be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. What is the reason for the share price to differ from the intrinsic value? For Quanex Building Products, I've compiled three fundamental factors you should further research:

  1. Financial Health: Does NX have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.

  2. Future Earnings: How does NX's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Are there other high quality stocks you could be holding instead of NX? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St updates its DCF calculation for every US stock every day, so if you want to find the intrinsic value of any other stock just search here.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.